The interdependent influence of lobbying and intellectual capital on new drug development
Vareska Van De Vrande, Annapoornima M. Subramanian, Moren Lévesque, Patricia Klopf
| Year of publication: |
2024
|
|---|---|
| Authors: | Vrande, Vareska van de ; Subramanian, Annapoornima M. ; Lévesque, Moren ; Klopf, Patricia |
| Published in: |
Research policy : policy, management and economic studies of science, technology and innovation. - Amsterdam : Elsevier, ISSN 1873-7625, ZDB-ID 1491698-8. - Vol. 53.2024, 2, Art.-No. 104938, p. 1-16
|
| Subject: | Intellectual capital | Lobbying breadth | Lobbying intensity | New drug development | Non-market strategy | Interessenpolitik | Lobbying | Immaterielle Werte | Intangible assets | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Pharmakologie | Pharmacology |
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1016/j.respol.2023.104938 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10014462740